A trial comparing platelet-rich plasma, autologous blood and dry needling for chronic patellar tendinopathy

Not Applicable

Recruiting

• Conditions: Patellar tendinopathy; Musculoskeletal Diseases; Patellar tendinitis

• Registration Number: ISRCTN93328851
• Lead Sponsor: Arthrex Inc. (USA)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-07-19
• Last Update Posted: 11 February 2019
• Study Completion: 2021-01-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 111

Inclusion Criteria

1. History (> 3 mo) of exercise-associated pain along the proximal insertion of the patellar tendon or pain or tenderness on palpation at this site or pain during provocative tests of the knee extensors
2. And having one of the following ultrasound finding:
2.1. Hypoechoic regions
2.2. Intratendinous tears
2.3. Neovascularisation
3. Being at least 18 years old, either sex

Exclusion Criteria

1. Bleeding disorders (hemophilia)
2. Taking anticoagulants (except aspirin)
3. Severe anemia
4. Cancer or metastases
5. Pregnant or breastfeeding women
6. Presence of infection at the time of evaluation
7. History of knee surgery
8. Inflammatory arthritis affecting the knee
9. Corticosteroid injections within 30 days preceding the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified